GRAIL
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.
GRAIL
Industry:
Biotechnology Health Care Health Diagnostics Medical Medical Device
Founded:
2016-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.grail.com
Total Employee:
501+
Status:
Active
Contact:
+1 650 542 0372
Email Addresses:
[email protected]
Total Funding:
2 B USD
Technology used in webpage:
SPF SSL By Default Content Delivery Network Domain Not Resolving Google Apps For Business Microsoft Azure DNS Google Google Cloud Amazon Route 53 Java EE
Similar Organizations
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
HiberCell
HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Eva
Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
MedicaMetrix
Advancing Prostate Disease Management
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
NurLabs
NurLabs develops label-free and reagent-free diagnostics to detect cancer early when it is most treatable.
Current Advisors List
Current Employees Featured
Founder
Investors List
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board investment in Series D - Grail
Huangpu River Capital
Huangpu River Capital investment in Series D - Grail
Illumina
Illumina investment in Series D - Grail
PSP Investments
PSP Investments investment in Series D - Grail
China Merchants Securities
China Merchants Securities investment in Series C - Grail
Hillhouse Capital Group
Hillhouse Capital Group investment in Series C - Grail
Ally Bridge Group
Ally Bridge Group investment in Series C - Grail
Genuity Science
Genuity Science investment in Series C - Grail
Blue Pool Capital
Blue Pool Capital investment in Series C - Grail
Sequoia Capital China
Sequoia Capital China investment in Series C - Grail
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-14 | Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL |
| 2019-12-16 | GRAIL Appoints Gautam Kollu as Chief Commercial Officer | GRAIL |
Official Site Inspections
http://www.grail.com Semrush global rank: 606.1 K Semrush visits lastest month: 74.53 K
- Host name: server-18-173-132-52.jfk52.r.cloudfront.net
- IP address: 18.173.132.52
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
